• Pharmacoeconomic Modelling in The Early Health Technology Assessment of Generic Pegylated Liposomal Doxorubicin

    Oct 1, 2017, 00:00

  • Treatment Patterns and Impact of Not Achieving Skin Clearance for Psoriasis Patients In Latin America

    Oct 1, 2017, 00:00

  • Impact Of Adenoma Surveillance Guidelines On The Future Demand Of Colonoscopies Associated To A Population-Based Colorectal Cancer Screening Program

    Oct 1, 2017, 00:00

  • Single Distribution, Two-Part, and Two-Component Finite Mixture Models for Predicting Smoking-Related Indirect Costs In Us Working Adults

    Oct 1, 2017, 00:00

  • Access To Psoriasis Drug Treatment Among Brazilian Patients

    Oct 1, 2017, 00:00

  • Matching-Adjusted Indirect Comparison (MAIC)- Sensitivity Analyses And Graphical Diagnostics

    Oct 1, 2017, 00:00

  • A Comparative Study on the Effect of Varee Vidaryadi Kashayam and Brihathyadi Kashayam in Lower Urinary Tract Infection

    Oct 1, 2017, 00:00

  • Does The Presence of An Orphan Drug Polcy Affect HTA Recommendations For Oncologic Orphan Drugs?

    Oct 1, 2017, 00:00

  • Group Concept Mapping As A Strategy for Defining Patient-Centered Outcomes In Proms and Pro-Pms

    Oct 1, 2017, 00:00

  • How Policy-Makers Should Understand Qualitative Evidence Regarding Public Opinion

    Oct 1, 2017, 00:00

  • Exploration Of Run-Time Requirements In Probabilistic Sensitivity Analysis Utilizing A Patient Level Based Type 2 Diabetes Simulation Model

    Oct 1, 2017, 00:00

  • Cetuximab in the First-Line Treatment of Ras Wild-Type Metastatic Colorectal Cancer with Liver-Limited Disease

    Oct 1, 2017, 00:00

  • Evaluation Of Baranya County Drug Ambulance's And Baranya County Police's School Based Drug Prevention Activity

    Oct 1, 2017, 00:00

  • Practicalities Of Using Real-World Evidence (RWE) In Comparative Effectiveness Research (CER)- Learnings From Imi-Getreal

    Oct 1, 2017, 00:00

  • Patient Preferences In The Treatment of Periodontal Disease- Multi-Dimensionality and Validity

    Oct 1, 2017, 00:00

  • Characterization Of Low Density Lipoprotein (LDL) Levels In Patients Diagnosed With Cronic Kidney Disease In Colombian Population In The Year 2016

    Oct 1, 2017, 00:00

  • Assessment of Knowledge, Attitude and Common Barriers Towards Reporting Adverse Drug Reactions by Public in Malaysia

    Oct 1, 2017, 00:00

  • Economic Evaluation of 10% Intravenous Immunoglobulin In Treatment of Primary Immunodeficiencies In Adults In The Russian Federation

    Oct 1, 2017, 00:00

  • Early Access Programs; A Useful Tool to Improve Access for Patients and Manufacturers

    Oct 1, 2017, 00:00

  • The Direct Cost of Patients With Multiple Sclerosis In France

    Oct 1, 2017, 00:00

  • Modelling The Burden Of Cardiovascular Disease In Brazil And The Impact Of Reducing Modifiable Risk Factors

    Oct 1, 2017, 00:00

  • The Risks In Translating Smartphone Strings For Medical Study Smartphones Apps Smartwatches

    Oct 1, 2017, 00:00

  • The Impact Of Cancer Drugs Fund Reforms On Reimbursement Of Oncology Drugs In The UK

    Oct 1, 2017, 00:00

  • The Clinical Burden Of Bladder Cancer To The Brazilian Society

    Oct 1, 2017, 00:00

  • Robotic Oncological Surgery Program Evaluation Using A Logic Model

    Oct 1, 2017, 00:00

  • Use of Biological Based Therapies and Assessment of Health Related Quality of Life Among Thalassaemia Patients

    Oct 1, 2017, 00:00

  • Treatment Patterns In Non-Small Cell Lung Cancer In France

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of a Knee Implants Standardization Model in Tertiary Hospitals

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Study of the use of Portable Coagulometers for the INR Control, In Comparison with Hospital Care, In Patients with Coagulation Disorders, Under the Context of the Mexican Public Health Setting

    Oct 1, 2017, 00:00

  • Sodium-Glucose Co-Transporter-2 (Sglt-2) Inhibitors And The Risk of Fractures of The Upper or Lower Limb In Patients With Type 2 Diabetes- A Nested-Case Control Study

    Oct 1, 2017, 00:00

  • Assessing The Cost-Effectiveness Of The Manchester Acute Coronary Syndrome (MACS) Decision-Aid- A Feasibility Study

    Oct 1, 2017, 00:00

  • An Economic Model To Estimate The Direct Economic Value Of Reducing The Severity Of Sepsis In French And Us Hospitals

    Oct 1, 2017, 00:00

  • Message from Co-Editors

    Oct 1, 2017, 00:00

  • Matching-Adjusted Indirect Comparison (MAIC) Of Crizotinib With Standard of Care In Progressed Nsclc ALK+ Patients Based On Real-World Evidence (RWE) And Clinical Trial Data In The Czech Republic

    Oct 1, 2017, 00:00

  • Adherence to Oral Antidiabetic Medication in Type 2 Diabetes Mellitus Clients in the Volta Region of Ghana

    Oct 1, 2017, 00:00

  • O Aumento Da Produção Científica E A Importância Da Biblioteconomia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Roflumilast As Add-On To Triple Inhaled Therapy Versus Triple Inhaled Therapy In Patients With Severe And Very Severe Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis In The Netherlands

    Oct 1, 2017, 00:00

  • Cost Per Life Saved Of Adjunctive Igm-Enriched Immunoglobulin Treatment Of Sepsis In Germany

    Oct 1, 2017, 00:00

  • Psychosocial Determinants of Depressive Illness Among Women Attending in Psychiatric Out Patients Department of Bangabandhu Sheikh Mujib Medical University(BSMMU) Dhaka, Bangladesh

    Oct 1, 2017, 00:00

  • Fair Pricing Of Orphan Drugs In Relation To Additional Health Gains And Disease Prevalence

    Oct 1, 2017, 00:00

  • Cardiovascular Disease Risk And Risk Factors Associated With Familial Hypercholesterolemia- A Systematic Review

    Oct 1, 2017, 00:00

  • The Humanistic Burden of Microsatellite Instability-High (MSI-H) Colorectal Cancer (CRC) and Metastatic CRC (MCRC) Patients Treated with Subsequent Line Therapy- A Systematic Review

    Oct 1, 2017, 00:00

  • Evaluating The Conceptual Equivalence Between Paper And Three Electronic Data Collection Modes Of The EQ-5D-5L Health Status Instrument

    Oct 1, 2017, 00:00

  • Comparison of Incremental Cost-Utility Ratios And Sales of Direct Oral Anticoagulants Across Eu-5 Countries

    Oct 1, 2017, 00:00

  • A Cost-Saving Model Of Nutrition Care Interventions For Malnourished Hospitalized Patients In Colombia

    Oct 1, 2017, 00:00

  • The Unique Characterisitcs Of Adoptive Immunotherapies For Health Economic Evaluations

    Oct 1, 2017, 00:00

  • Effectiveness Of Identifying A Cancer Patient In The Hospital Sector In Northern-Norway - Analyses Based On Updated Regional Performance Database

    Oct 1, 2017, 00:00

  • Cost Per Response Analysis of Nivolumab Versus Everolimus in the Treatment of Patients Previously Treated with Advanced Renal Cell Carcinoma – Brazil Private Health Care System Perspective

    Oct 1, 2017, 00:00

  • Economic Evaluation of New HCV Treatments in Egypt

    Oct 1, 2017, 00:00

  • Critical Assessment Of Atmp Market Access Outcomes On A National-Level Across EU5 Countries

    Oct 1, 2017, 00:00

  • Assessing The Cost Effectiveness Of A New, First-In-Class Triple Fixed Dose Combination Therapy For COPD Patients

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ibrutinib in Patients with Relapsed or Refractory (RR) Chronic Lymphocytic Leukaemia (CLL) in England

    Oct 1, 2017, 00:00

  • Evaluating Adverse Events Costs in Cancer Patients in Lebanon From Two Payers Perspective

    Oct 1, 2017, 00:00

  • A Qualitative Interview Study to Explore the Patient Experience of Locally Advanced or Metastatic Pancreatic Cancer and Explore the Content of Patient-Reported Outcome Measures

    Oct 1, 2017, 00:00

  • Burden of Renal Transplant Among A Cohort of US Medicare Beneficiaries With Autosomal Dominant Polycystic Kidney Disease

    Oct 1, 2017, 00:00

  • A Cross Section Study on Prevalence of Neuro-Psychiatric Disorders and Quality of Life in Post Stroke Patients

    Oct 1, 2017, 00:00

  • Roche Oncology Data in Open Access- An Innovative Step for Scientists

    Oct 1, 2017, 00:00

  • Budget-Impact of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In Greece

    Oct 1, 2017, 00:00

  • Hemodynamic Monitoring Can Reduce Costs on High Risk Patients WHO Underwent Large/Medium Surgical Procedures

    Oct 1, 2017, 00:00

  • The Analysis of the Number of Same-Day Surgery Cases in 2015 in Hungarian Hospitals

    Oct 1, 2017, 00:00

  • Implementing Managed Entry Agreements in Practi The Dutch Reality Check

    Oct 1, 2017, 00:00

  • A Literature Analysis Of Cost Studies On Cancer

    Oct 1, 2017, 00:00

  • Budget Impact Analysis (BIA) Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

    Oct 1, 2017, 00:00

  • Clinical Drivers Of Economic Models And Utility Mapping Algorithms In Schizophrenia

    Oct 1, 2017, 00:00

  • The Clinical Burden Of Head And Neck Cancer To The Brazilian Society

    Oct 1, 2017, 00:00

  • Impact Of A Pharmacist-Led Intervention On The Knowledge Of Appropriate Use Of Peak Flow Meter And Asthma Action Plan Among Pharmacy Students- A Simulated Patient Approach

    Oct 1, 2017, 00:00

  • Accessibility To Oncologic Treatment In Sus Public Health Systems And Obamacare

    Oct 1, 2017, 00:00

  • Association of Health-Related Quality of Life (HRQOL) and Healthcare Resource Utilization (HCRU) in Checkmate 141, A Phase 3 Study of Nivolumab Versus Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refrac ...

    Oct 1, 2017, 00:00

  • Subcutaneous vs Intravenous Administration of Trastuzumab in Her2+ Breast Cancer Patients- A Montenegrin Cost-Minimization Analysis

    Oct 1, 2017, 00:00

  • Correlation Analysis Between Health State Values Derived From EQ-5D-5L And EQ-VAS in Japanese Breast Cancer Patients

    Oct 1, 2017, 00:00

  • Tissue/Site Agnostic Regulatory Approval of Oncology Drugs- Are Htas Ready For A New Era In Personalised Medicine?

    Oct 1, 2017, 00:00

  • Using An Instrumental Variable Approach To Estimate Causal Treatment Effects In An Observational Cohort of Patients With Chronic Obstructive Pulmonary Disease

    Oct 1, 2017, 00:00

  • The Greta Study- Generating Real-World Evidence about Bevacizumab Treatment of Metastatic Colorectal Cancer by Linking Cancer Registries and Healthcare Databases in Italy

    Oct 1, 2017, 00:00

  • UK Utility Elicitation in Patients with Follicular Lymphoma

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Long-Acting Recombinant FSH (Corifollitropin Alfa) Versus Recombinant FSH (Follitropin Alfa) In Assisted Reproduction Techniques in the Management of Infertility in Iran

    Oct 1, 2017, 00:00

  • Pricing And Time-To-Market For Monoclonal Antibodies In Italy

    Oct 1, 2017, 00:00

  • The Attitude Of Polish Physicians Towards Introduction Of E-Prescription – A Questionnaire Survey

    Oct 1, 2017, 00:00

  • A Claims Data Analysis of Biological Agents for Psoriatic Arthritis In Germany

    Oct 1, 2017, 00:00

  • Comparative Analysis Of Medicine's Purchassing Prices Of "Additional List"(Aphp Versus French Hospitals Formely Under Overall Allocation)

    Oct 1, 2017, 00:00

  • Accounting for Capacity Constraints In Economic Evaluations of Stratified Medicine- A Systematic Review

    Oct 1, 2017, 00:00

  • Characterization Of Health Care Utilization And Cost Of Hemophilia A And B In Real-Life- A 4-Year Follow-UP Study In Finland

    Oct 1, 2017, 00:00

  • Assessing The Healthcare Cost of Diabetic Non-Small Cell Lung Cancer Patients Compared To Non-Small Cell Lung Cancer Patients

    Oct 1, 2017, 00:00

  • Cetuximab in The Treatment of Mcrc Liver Limited Disease- A Systematic Review

    Oct 1, 2017, 00:00

  • Impact Of Weight Change After Quitting Cigarettes On All-Cause And Cause-Specficic Mortality In Middle-Aged Male Smokers- National Health Screening Cohort Study

    Oct 1, 2017, 00:00

  • Investing In Skilled Specialists To Grow Hospital Infrastructure And Improve Quality

    Oct 1, 2017, 00:00

  • Withdrawn

    Oct 1, 2017, 00:00

  • Subgroup Specific Medicine- Finding Patients With Poor Therapy Response

    Oct 1, 2017, 00:00

  • The Economic Burden Of Congenital Cytomegalovirus-Related Hospitalizations In The United States

    Oct 1, 2017, 00:00

  • Replicating The Medication Adherence Reasons Scale (Mar-Scale) Factor Structure In People Using Daily Orals For Depression, Gastroesophageal Reflux Disease, Rheumatoid Arthritis, And Epilepsy

    Oct 1, 2017, 00:00

  • Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc)- Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Stud ...

    Oct 1, 2017, 00:00

  • Evidence Map of Cost-Benefit, Cost-Effectiveness and Cost-Utility Models In Dementia Published Since 1960

    Oct 1, 2017, 00:00

  • A Comparison Of Antiretroviral Drugs Approved In The US And Europe In The Period 1987-2015

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Low-Dose Methoxyflurane For The Treatment of Moderate-To-Severe Trauma Pain In Sweden

    Oct 1, 2017, 00:00

  • Daily Living With Early Retinal Diseases- The Patient Perspective

    Oct 1, 2017, 00:00

  • Various Strategies of Management of Patients With Diabetic Polyneuropathy- Modeling of Clinical Outcomes And Pharmacoeconomic Analysis

    Oct 1, 2017, 00:00

  • Use Of Healthcare Resources And Associated Costs Of Idiopathic Pulmonary Fibrosis In Spain- A Real-Life Study

    Oct 1, 2017, 00:00

  • Financiamiento Del Cribado Y Tratamiento De La Nefropatía Diabética En El Primer Nivel De Atención Por El Seguro Integral De Salud, Perú

    Oct 1, 2017, 00:00

  • Systematic Review Of Markov Model-Based Economic Evaluation Studies For Cervical Cancer Screening Strategies- Latin America Countries Panorama

    Oct 1, 2017, 00:00

  • Efecto Del 1B8 EN EL Tratamiento De Pacientes Con Linfoma No Hodgkin Cd20+

    Oct 1, 2017, 00:00

  • A Three Month Interim Analysis of Treatment Satisfaction with Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis in the UK- The Patient Reported Outcomes with Fingolimod in Local Experience (Profile) Study

    Oct 1, 2017, 00:00

  • Effectiveness of Surgical Stabilization of Rib Fractures with or without Flail Chest – A Systematic Review

    Oct 1, 2017, 00:00

  • Description Of The Chinese Health Care System After The Health Care Reform

    Oct 1, 2017, 00:00

  • Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Mexico

    Oct 1, 2017, 00:00

  • Innovative Pricing and Reimbursement Schemes – The What, Why, Which, and How

    Oct 1, 2017, 00:00

  • Life Expectancy And Costs of Transthyretin Familial Amyloid Polyneuropathy

    Oct 1, 2017, 00:00

  • Multiplatform Tumor Profiling Delivers Value Based Health Care In Refractory Cancer Patients

    Oct 1, 2017, 00:00

  • Dialysis Status In Patients With Chronic Kidney Disease In Korea- Based On 12-Years National Sampel Cohort Database

    Oct 1, 2017, 00:00

  • Inpatient Medication Errors And Pharmacist Intervention At Ministry Of Health Public Hospital In Riyadh, Saudi Arabia

    Oct 1, 2017, 00:00

  • Treatment Patterns of Chronic Heart Failure (CHF) In Argentina

    Oct 1, 2017, 00:00

  • Metanálise De Segurança Do Tratamento Medicamentoso De Pacientes Com Transtorno Do Déficit Da Atenção com Hiperatividade E Ansiedade

    Oct 1, 2017, 00:00

  • Annual Costs of Best Supportive Care for Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) in Germany

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Apremilast for the Treatment of Active Psoriatic Arthritis In Greece

    Oct 1, 2017, 00:00

  • Impact Of Multi-Drug Resistance On HTA Assessment Of Antibiotics In France, Germany, United Kingdom

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Indacaterol/Glycopyrronium in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) in Colombia

    Oct 1, 2017, 00:00

  • Resource Allocation For Treating Alcohol And Drug Misuse In Psychosocial Care Center In Brazil- Is Current National Funding Enough For Covering Its Total Costs?

    Oct 1, 2017, 00:00

  • Deflazacort or Prednisone Treatment for Duchenne Muscular Dystrophy- A Meta-Analysis of Disease Progression Rates in Recent Multicenter Clinical Trials

    Oct 1, 2017, 00:00

  • Patient Empowerment for Healthcare Decision-Making Assessing Oncology Innovation Through Multicriteria Decision Analysis

    Oct 1, 2017, 00:00

  • Involvement Of Community Pharmacists In Public Health Priorities- A Multi-Center Descriptive Survey In Ethiopia

    Oct 1, 2017, 00:00

  • A Systematic Review of Comparative Effectiveness of Ezetimibe And PCSK9 Inhibitors

    Oct 1, 2017, 00:00

  • Healthcare Insurance Spending At Year 2 Between Treatment Groups Following Diagnosis Of Nontuberculous Mycobacterial Lung Disease In The US

    Oct 1, 2017, 00:00

  • The French Compassionate Use Of Medicinal Products Programme- A Drastic Increase Of Expenditure Over The 2012-2016 Period

    Oct 1, 2017, 00:00

  • Spirometry Comparison Of Lung Fuction Between Coalminers And Non-Coalminers

    Oct 1, 2017, 00:00

  • Survival Differences In Heart Failure Patients With And Without Iron Deficiency/Anemia And By Oral And Intravenous Iron Treatment

    Oct 1, 2017, 00:00

  • Costo-Utilidad De La Vacunación Contra Varicela En Perú

    Oct 1, 2017, 00:00

  • An Analysis of The Current Jordanian Pricing System and Developing Recommendations for Its Enhancemnet

    Oct 1, 2017, 00:00

  • A Review Of Methods For Item Selection In The Development Of A Descriptive System For Quality Of Life Instrument

    Oct 1, 2017, 00:00

  • Women's Preferences- A Discrete-Choice Experiment For Treatment of Menorrhagia with Uterus-Preserving Therapy

    Oct 1, 2017, 00:00

  • Real-World Cost Effectiveness Comparison Of Symbicort Turbuhaler And Duoresp Spiromax In UK Patients With Asthma Or Chronic Obstructive Pulmonary Disease

    Oct 1, 2017, 00:00

  • Deep Brain Stimulation For Parkinson's Disease- Comparison Between Unilateral And Bilateral Implantation

    Oct 1, 2017, 00:00

  • Determination Of Needs And Priorities In Order To Better Organization Of Antenatal Courses

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of Tacrolimus XL in Comparison to Generic Tacrolimus from the Public Healthcare Sector in Mexico

    Oct 1, 2017, 00:00

  • Migraine Burden and Costs- A Nationwide Population-Based Controled Cohort Study Using The French EGB Database

    Oct 1, 2017, 00:00

  • Outcome Measures used to Assess Interventions for Asthma Control- A Systematic Review

    Oct 1, 2017, 00:00

  • Suspected Adverse Reactions (SARS) To Systemic Glucocorticoid Usage In Dogs In Primary Veterinary Practice In The UK

    Oct 1, 2017, 00:00

  • Treatment Pattern Of Patients Diagnosed With Prostate Cancer In Korea- A Trend Analysis Using Nationwide Health Insurance Database

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Fingolimod for The Treatment Multiple Sclerosis In Korea

    Oct 1, 2017, 00:00

  • Factors Associated with Quality of Life(QOL) In Peripheral Arterial Disease(PAD) Patients in Korea- Results from Pad Outcomes Research(OR)

    Oct 1, 2017, 00:00

  • A Cost-Utility Analysis of Dutasteride Plus Tamsulosin Combination Therapy Versus Tamsulosin Monotherapy in The Treatment of Benign Prostatic Hyperplasia in Iran

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Brazil

    Oct 1, 2017, 00:00

  • The Cost-Effectivness Analysis of The Latent Tuberculosis Infection Screening For Adults 40 Years old In South Korea

    Oct 1, 2017, 00:00

  • Patients With High Comorbidity And Transitioning To Dialysis At High Risk Of Suboptimal Antihypertensive Medication Prescription Use- Results From A Brazilian National Cohort (BRAZPD) Of Peritoneal Dialysis

    Oct 1, 2017, 00:00

  • Alternative Reimbursement Models for High Cost Health Technologies

    Oct 1, 2017, 00:00

  • Economic Impact Of Moderate And Severe Neurotrophic Keratitis In Italy

    Oct 1, 2017, 00:00

  • A Snapshot of Medication Adherence Across Three European Countries- Application of Common Methodology

    Oct 1, 2017, 00:00

  • The Burden And Cost Of Illness Of Gout In Secondary Care In England

    Oct 1, 2017, 00:00

  • Health Loss Due To Market Access Delays And Reimbursement Restrictions In First-Line EGFR-Positive Non-Small Cell Lung Cancer In The EU5 Countries

    Oct 1, 2017, 00:00

  • Preferences of The General Population To Avoid Oral Health Outcomes- Results of A Bayesian Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • A Typology-Based Decisional Framework To Support Market Access And Reimbursement Decisions For Personalised Medicines

    Oct 1, 2017, 00:00

  • Cost Benefit Analysis in The Treatment of Severe Osteoporosis from The Public Healthcare System Perspective in Mexico

    Oct 1, 2017, 00:00

  • Myocardial Revascularization- Comparative Cost Study In South America Health Care System

    Oct 1, 2017, 00:00

  • An Accessible Comparison Of Traditional Statistical And Machine Learning Approaches To Analysis Of Real World Data- Which, When And Why?

    Oct 1, 2017, 00:00

  • Cost-Consequences Of Using Fluciclovine (F 18) For The Diagnosis And Staging Of Recurring Prostate Cancer

    Oct 1, 2017, 00:00

  • Technical Challenges in Cost-Effectiveness Analysis for Oncology Treatments- Identifying Frequent Issues in Modelling From Nice Perspective

    Oct 1, 2017, 00:00

  • Trastuzumab As A Therapy Versus Other Treatment Regimens In Patients With HER2 Positive Breast Cancer- A Systematic Review of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Sink or Swim- How Can Asthma Biologics Successfully Sail the Rough Waters of EU5 Market Access?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ponatinib in The Treatment of Patients With Accelerated or Blast Phase - Chronic Myeloid Leukemia in Greece

    Oct 1, 2017, 00:00

  • A Cost-Utility Analysis of Artificial Urinary Sphincter Versus Advance Male Sling In Post Prostatectomy Stress Urinary Incontinen A Canadian Healthcare Perspective

    Oct 1, 2017, 00:00

  • Effects of Propofol Versus Other General Anesthesia in Children Younger Than 3 Years of Age- A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Developing a Multi-Criteria Framework for Innovation and Biologic Drugs Assessment Decision Making in Egypt

    Oct 1, 2017, 00:00

  • How Should We Test For Pre-Term Labour? An Economic Model And Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Healthcare Resource Use and Costs In Patients With Major Depressive Disorder Switching From A Generic To A Branded Antidepressant

    Oct 1, 2017, 00:00

  • A Systematic Review of Pharmacoeconomic Evaluation of Erlotinib in The First-Line Treatment of Advanced Non-Small Cell Lung Cancer

    Oct 1, 2017, 00:00

  • Impact of Drug Related Problems on Blood Pressure Control In Patients With Hypertension In Indonesian Primary Health Care

    Oct 1, 2017, 00:00

  • Population Health Impact of Omalizumab over 15 Years of Experience in Moderate to Severe Allergic Asthma

    Oct 1, 2017, 00:00

  • Patient’s Journey Through Acute Myeloid Leukemia (AML)- Understanding AML’s Humanistic Impact Through an International Patient-Centric Qualitative Study

    Oct 1, 2017, 00:00

  • Costs Associated With Transthyretin Familial Amyloid Polyneuropathy Progression

    Oct 1, 2017, 00:00

  • Financial Optimization in The Treatment for Rheumathoid Artritis in Patients Receiving Conventional Dmard Therapy

    Oct 1, 2017, 00:00

  • Quality of Life Assessment in Ild – A Comparison of EQ-5D with The Disease-Specific K-Bild

    Oct 1, 2017, 00:00

  • Screening For Asymptomatic Atrial Fibrillation- Its Effectiveness And Cost-Effectiveness Of Repeated Ecg In Poland

    Oct 1, 2017, 00:00

  • Real-World Management And Outcomes Of Patients With Multiple Myeloma In Romania And Poland

    Oct 1, 2017, 00:00

  • Disease-Specific Patient-Reported Outcome Instruments In Sickle Cell Disease- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Empagliflozin In Patients With Type 2 Diabetes Mellitus At High Cardiovascular Risk In Poland

    Oct 1, 2017, 00:00

  • Analysis of Using Irp as A Launch Price Setting Mechanism

    Oct 1, 2017, 00:00

  • Posterior Capsule Opacification After Cataract Extraction And Related Healthcare Costs In Germany – A Claims Data Analysis On The Impact Of The Implanted Type Of Intraocular Lenses

    Oct 1, 2017, 00:00

  • The use of Scientific Evidence to Support Judicial Decisions

    Oct 1, 2017, 00:00

  • Análise De Custo-Efetividade Do Tratamento Diretamente Observado Da Tuberculose

    Oct 1, 2017, 00:00

  • Estimates of PFS, TTNT Per Treatment Line and their Relationship for Multiple Myeloma Patients

    Oct 1, 2017, 00:00

  • The Impress Of Pharmacoeconomics In Pricing Decisions In IFDA

    Oct 1, 2017, 00:00

  • Análisis De Costo Efectividad Del Uso De Budesonida/Formoterol Frente A Salmeterol/Fluticasona, En Pacientes Con Asma Moderada Y Severa En Colombia

    Oct 1, 2017, 00:00

  • Obinutuzumab vs. Ibrutinib in the Treatment of Treatment-Naïve Patients with Chronic Lymphocytic Leukemia —A Cost-Comparison Study in Colombia

    Oct 1, 2017, 00:00

  • Efficacy Of Antioxidant Supplements On Prevention And Amelioration Of Cisplatin-Induced Nephrotoxicity- A Systematic Review And Meta-Analysis Of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Cognitive assessments on portable devices- A comparison between phones and tablets

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Secukinumab use Versus Tnf-Α Inhibitors, in Patients with Ankylosing Spondilytis

    Oct 1, 2017, 00:00

  • Identifying Evidence on The Cost-Effectiveness of Treatments And Costs/Resource Use And Quality of Life of Patients with Follicular Lymphoma And Marginal Zone Lymphoma- Systematic Reviews

    Oct 1, 2017, 00:00

  • Would a Two-Dose Rotavirus Vaccine Improve Health Outcomes While Reducing Costs in the Sultanate of Oman?

    Oct 1, 2017, 00:00

  • Comparing Surgical Therapy and Hormonal Therapy In Incidence Of Cardiovascular Disease Among Prostate Cancer Patients In Korea

    Oct 1, 2017, 00:00

  • Use Of Pragmatic Clinical Trials To Support Drug Launch

    Oct 1, 2017, 00:00

  • Growth of National Health Insurance Expenditure Related To Antidiabetics And Their Projections Up Until 2020

    Oct 1, 2017, 00:00

  • Antithrombotic Treatments in Patients with Acute Ischemic Stroke and Non-Valvular Atrial Fibrillation Before Introduction of Non-Vitamin K Antagonist Oral Anticoagulants Into Practice in Korea

    Oct 1, 2017, 00:00

  • Impact of Cytomegalovirus Infection and Treatment on Patient-Reported Outcomes In Haematopoietic Cell Transplant Recipients

    Oct 1, 2017, 00:00

  • Tools For Improving Efficiency In Clinical Management And Safety Of Hypertensive Patients. Efigie-hta Project

    Oct 1, 2017, 00:00

  • Antibiotics Treatment Patterns As A Costs And Resource Utilization Predictor Among Patients Submitted To Bariatric Surgery- Analysis of A Large Health Insurance Claims Database

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ponatinib in The Treatment of Patients with Acute Lymphoblastic Leukemia with Philadelphia Chromosome Positive (PH+ ALL), Suitable for Allogeneic Stem Cell Transplant, in Greece

    Oct 1, 2017, 00:00

  • Table of Contents

    Oct 1, 2017, 00:00

  • Cost-Savings Due To Implementation of A Screening Algorithm For Diagnosis of Rheumatoid Arthirits in Colombia

    Oct 1, 2017, 00:00

  • Epidemiological Estimates and Treatment Practice Pattern in Polycythemia Vera Patients in Turkey- Results Based on an Expert Panel

    Oct 1, 2017, 00:00

  • The Resource And Cost Consequences Of Using Antibiotic Coated Intramedullary Nails Compared To Non-Coated Nails In Open Tibia Fractures Across Four European Centres

    Oct 1, 2017, 00:00

  • Differences And Decision Drivers In The Hta-Outcome Category Lower Benefit Between Iqwig And G-Ba Assment In The German Amnog Process

    Oct 1, 2017, 00:00

  • Methodological Analyses Of Budget Impact Models Submitted To The Haute Autorité De Santé (HAS) (French National Authority For Health)

    Oct 1, 2017, 00:00

  • Impact Of Using Overall Survival Or Progression-Free Survival In Outcomes-Based Pricing Arrangements

    Oct 1, 2017, 00:00

  • The Role Of Disability On Early Retirement

    Oct 1, 2017, 00:00

  • The Effect of Value Based Insurance Designs on Costs- A Systematic Review

    Oct 1, 2017, 00:00

  • Real-World Treatment Patterns And Time To Discontinuation In Rheumatoid Arthritis Patients In The US

    Oct 1, 2017, 00:00

  • Characterization Of Low Density Lipoprotein (LDL) Levels In Patients Diagnosed With Diabetes Mellitus In Colombian Population In The Year 2016

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Study To Evaluate Insulin Glargine Compared With NPH Insulin In Patients With Type 2 Diabetes Uncontrolled With Oral Anti-Diabetic Agents In Hong Kong

    Oct 1, 2017, 00:00

  • Evaluation of the Cost Effectiveness of the Treatment of Mild and Moderate Alzheimer’s Disease

    Oct 1, 2017, 00:00

  • Assessment And Simulation of Costs And QOL For Sublingual Immunotherapy In Paediatric Asthma Vs Placebo- Preliminary Data

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Fulvestrant 500 Mg in Endocrine Therapy-Naïve Women with Hormone Receptor-Positive Advanced Breast Cancer in The UK

    Oct 1, 2017, 00:00

  • Immunobiological Use Profile In The Service of Rheumatology of A Heatlhcare Provider

    Oct 1, 2017, 00:00

  • Cost Assessment Of Acquired Resistant Bacterial Infection In A Hospital In The Dominican Republic

    Oct 1, 2017, 00:00

  • Alternative Sources For Health Care Funding- Public Health Taxes In Hungary Between 2011-2016

    Oct 1, 2017, 00:00

  • Could Embase Emtree Index Search Terms Be Focused To Reduce Numbers To Screen In Clinical Systematic Reviews?

    Oct 1, 2017, 00:00

  • How Far Equity Has Been Achieved in the Indonesian Universal Health Coverage?

    Oct 1, 2017, 00:00

  • Lifetime Risk of Revision Following Joint Replacement- Evidence From Routinely-Collected Data

    Oct 1, 2017, 00:00

  • Generating Patient Insights In Dry Eye Disease With A Social Media Listening Study

    Oct 1, 2017, 00:00

  • Personalised Health Definitions – A New Supplemental Framework to Interpret Individuals’ Responses on the EQ-5D-VAS

    Oct 1, 2017, 00:00

  • Cost Analysis of Lung Cancer in China

    Oct 1, 2017, 00:00

  • Second-Line Treatment for Steroid-Refractory Graft-Versus-Host Disease with Mesenchymal Stromal Cells. A Conceptual Disease Model

    Oct 1, 2017, 00:00

  • Comparison Of Hospital Resource Utilization Between Elective And Emergent Admissions Among Patients Undergoing Inpatient Colorectal Surgery

    Oct 1, 2017, 00:00

  • The Coordinated Management Of Patient With Mental Illness In Spain By Hospital, Primary Care And Community Pharmacists (3PH), A Resource Optimization Model

    Oct 1, 2017, 00:00

  • Avaliação Da Indicação Terapêutica Da Metilprednisolona No Tratamento Adjunto De Pessoas Portadoras De Pneumonia Por Pneumocystis Carinii

    Oct 1, 2017, 00:00

  • Penetration of Peripheral Vascular Interventions in Hungary

    Oct 1, 2017, 00:00

  • Prevalence of Anticonvulsants Utilization at a Tertiary Hospital in Southeast Nigeria; Bridging the Gaps Between Facilities Outcomes and Policies Through Evidence-Based Reports

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Insulin Pumps Versus Multiple Daily Insulin (MDI) Injection In Type 1 Diabetes In India From Societal Perspective

    Oct 1, 2017, 00:00

  • Comparative Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants (NOACS) And Warfarin In The Scottish Atrial Fibrillation Population- The Value of Real World Evidence

    Oct 1, 2017, 00:00

  • Long-Term work Productivity improvement from Phase 3 Baricitinib Ra-Beam Study- Latin American Subgroup Analysis

    Oct 1, 2017, 00:00

  • Medication Adherence and Quality of Life of Uncontrolled Hypertension Patients in Korea

    Oct 1, 2017, 00:00

  • Health Technologies' Taxonomy and Challenges To Apply The Assessment

    Oct 1, 2017, 00:00

  • Estratégias Intitucionais Como Mecanismo De Racionalização Das Demandas Judiciais De Medicamentos

    Oct 1, 2017, 00:00

  • Pattern Of Anti-Infective Drugs Use In A Tertiary Healthcare Facility In Nigeria

    Oct 1, 2017, 00:00

  • Time to Access- Too Fast, Too Slow, or Just Right? An Evolving Public Reimbursement Landscape of Drugs For Rare Diseases In Canada

    Oct 1, 2017, 00:00

  • Implementation Of A Data Mining Model Within A Monitoring Web-Based Tool To Assess HER2 Breast Cancer Status Using The Her-France Real World Database

    Oct 1, 2017, 00:00

  • Quality of Life in Patients with Chronic Heart Failure in Slovak Republic

    Oct 1, 2017, 00:00

  • Assessment Of Knowledge And Perceived Practices Of Antimicrobial Stewardship Among Malaysian Future Healthcare Professionals

    Oct 1, 2017, 00:00

  • Fractional Polynomial NMA Models For Survival Analyses- Results From A Simulation Study

    Oct 1, 2017, 00:00

  • Conceptualization, Development, And Internal And External Validation of A ‘Whole Disease’ Model for Chronic Obstructive Pulmonary Disease

    Oct 1, 2017, 00:00

  • Changes in acute medication cost observed in cluster headache patients treated with sphenopalatine ganglion (SPG) stimulation- a U.K. NHS-specific analysis based on data from the pathway R1 registry

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Alternative Measles-Mumps-Rubella Childhood Vaccination Schedules In Denmark

    Oct 1, 2017, 00:00

  • Cost Of Hospital Treatment For Severe And Moderate-To-Severe Influenza In Russia

    Oct 1, 2017, 00:00

  • Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C- A Decision Analysis from The Perspective of The Brazilian Public Health System

    Oct 1, 2017, 00:00

  • Barriers To Effective Treatment Of Patients With Cll In Poland In Comparison To The United Kingdom

    Oct 1, 2017, 00:00

  • How Will Proposed Changes To The Nice Highly Specialised Technology Evaluation Process Impact Patient Access To Innovative Drugs for Rare Diseases?

    Oct 1, 2017, 00:00

  • A Conceptual Model of The Economics of Visualization In Diagnostics and Surgery

    Oct 1, 2017, 00:00

  • Impact of Comorbidities on The Risk And Cost of Hospitalization In Hiv-Infected Patients- Real World Data From The Abruzzo Region

    Oct 1, 2017, 00:00

  • Reported Limitations In Economic Models for Treatments of Schizophrenia- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization And Costs For Total Hip Arthroplasty- Benchmarking The Anterior Approach In The Medicare Population

    Oct 1, 2017, 00:00

  • Access Perceptions- A Key Driver Of Non-Small Cell Lung Cancer (NSCLC) Targeted Therapy Prescription In Russia

    Oct 1, 2017, 00:00

  • The Efficiency Path To Universal Health Coverage- Derivation Of Cost-Effectiveness Thresholds Based On Health Expenditures And Life Expectancy. Updated Country-Level Estimates For 194 Countries

    Oct 1, 2017, 00:00

  • Comparison Of Elderly Care Recipients’ Social Care-Related Quality Of Life (SCRQOL) With Health Related Quality Of Life (HRQOL) In Japan

    Oct 1, 2017, 00:00

  • Systematic Review of Observational Studies of Interferon-Free Treatments for Chronic Hepatitis C

    Oct 1, 2017, 00:00

  • Cost Associated with Self-Expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement in Latin America

    Oct 1, 2017, 00:00

  • Assessing the Consistency in Reporting of Adverse Events Across Data Sources for Multiple Myeloma Treatment

    Oct 1, 2017, 00:00

  • Quality Assured Use of Pharmaceuticals- Does German Gba Follow Ema?

    Oct 1, 2017, 00:00

  • Health Economic Evaluation Of Elective Cardioversion Of Atrial Fibrillation With Rivaroxaban Versus Vitamin K Oral Antagonists

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Venetoclax For Treatment Of Refractory/Relapsed Chronic Lymphocytic Leukemia With Or Without 17P Deletion In Bulgaria

    Oct 1, 2017, 00:00

  • Feasibility Assessment- The Impact of A Reduced Operating Room Footprint System On The Resources Required For Instrument Management In Deformity Surgery From An Italian Hospital Perspective

    Oct 1, 2017, 00:00

  • Real Life Cost of Treatment and Follow-Up in Pancreatic Adenocarcinoma Patients Treated At The Antwerp University Hospital (UZA), Belgium

    Oct 1, 2017, 00:00

  • Management Of Duchenne Muscular Dystrophy (DMD)- Results From A Global Survey Of Healthcare Providers From Nine Countries

    Oct 1, 2017, 00:00

  • An Analysis Of HTA And Reimbursement Processes In Eunethta Partner Countries- Implications For Implementing HTA Cooperation

    Oct 1, 2017, 00:00

  • Consulta Pública Como Instrumento De Diálogo E Negociação Entre Indústria E Governo

    Oct 1, 2017, 00:00

  • Comparing Inhaled Corticosteroids and Long-Acting Beta Agonists Combination To Inhaled Corticosteroids on Risk of Ischemic Cardiovascular Diseases in Patients with Asthma

    Oct 1, 2017, 00:00

  • Real-World Treatment Patterns Among Patients Initiating on Statins in England

    Oct 1, 2017, 00:00

  • Safety And Efficacy of Osimertinib As A Therapy In Patients With Egfr T790M Positive Non Small Cell Lung Cancer Patients- A Systematic Review

    Oct 1, 2017, 00:00

  • Indirect Comparisions Presented In German Benefit Assessments – Status Quo and Quo Vadis?

    Oct 1, 2017, 00:00

  • Centralization And Complexity Of Drug Market Access Process Across Italian Regions

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Ultrasound Screening, Cancer Patients, To Detect Asymptomatic Thrombosis

    Oct 1, 2017, 00:00

  • The Burden of Genital Warts In Latin America- A Review of the Evidence

    Oct 1, 2017, 00:00

  • Comparison Of Catheter-Related Complications Between Manually-Prepared Saline Flush Syringes And Commercially Available Pre-Filled Saline Flush Syringes

    Oct 1, 2017, 00:00

  • Consumers’ Assessment On Integrated Delivery System In Remote Areas In Taiwan

    Oct 1, 2017, 00:00

  • Antiviral Medicines Assessment- What Is Driving High Clinical Added Value In France?

    Oct 1, 2017, 00:00

  • Retrospective Analysis of The Ceesp Efficiency Opinions and Eligibility Criteria for Assessment Since Its Creation

    Oct 1, 2017, 00:00

  • The Comparative Pharmacoeconomic Analysis Of Using Absorb Bioresorbable Vascular Scaffold System For Patients With St Segment Elevation Myocardial Infarction (STEMI)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Evaluation of A Two-Dose Human Papillomavirus Vaccination Schedule in Colombia

    Oct 1, 2017, 00:00

  • Effectiveness of a Pharmacist-Delivered Smoking Cessation Program in the State of Qatar- A Randomized Controlled Trial

    Oct 1, 2017, 00:00

  • The Impact of Pharmacist-LED Medication Therapy Management on Medication Adherence in Patients with Type 2 Diabetes Mellitus- A Randomized Controlled Study

    Oct 1, 2017, 00:00

  • Cost Burden Associated with Advanced Non-Small Cell Lung Cancer (A-NSCLC)- Impact of Disease Stage

    Oct 1, 2017, 00:00

  • The Multi-Criteria Decision Analysis in the Priority Setting of Emerging Medicines

    Oct 1, 2017, 00:00

  • Ecocardiograma Sob Estresse Com Dobutamina- Alternativa Econômica E Exeqüível Na Avaliação De Risco Cardiovascular Pré Transplante Renal

    Oct 1, 2017, 00:00

  • Systematic Review Of Pivotal Studies Of Oncology Drugs Authorized In Italy Since 2013- Correlation Between Studies’ Main Characteristics And Time To Patient

    Oct 1, 2017, 00:00

  • The Role Of Companion Diagnostics In HTAS Of Drugs In France, Germany And The UK

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Vedolizumab for the Treatment of Adult Patients with Moderately-to-Severely Active Ulcerative Colitis in Russia

    Oct 1, 2017, 00:00

  • The Role of Community Pharmacists in Patient Counselling and Health Education- A Survey of Their Knowledge and Level of Involvement in Relation to Type 2 Diabetes Mellitus

    Oct 1, 2017, 00:00

  • What Underlies The Observed Hospital Volume-Outcome Relationship?

    Oct 1, 2017, 00:00

  • Evaluation of Safety and Efficacy of Propofol for Procedural Sedation in Pediatric Population- A Meta-Analysis

    Oct 1, 2017, 00:00

  • Occurrence Of Skeletal-Related Events (SRE) In Patients With Solid Tumors (ST) And Multiple Myeloma (MM) In Germany- Early Versus Late Initiation of Sre Preventative Agents (SPA)

    Oct 1, 2017, 00:00

  • The Cost Of Prescribing Direct Oral Anticoagulants (DOACS) – There Is A Drug Cost But What Else?

    Oct 1, 2017, 00:00

  • Burnout Syndrome among Healthcare Professionals working in Gondar University Hospital, Northwest Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Systematic Review and Meta-Analysis of The Efficacy And Safety Of Amfepramone and Mazindol As A Monotherapy for The Treatment of Obese or Overweight Patients

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Diagnostic Technologies for Dementia- A Systematic Review of Economic Evaluations

    Oct 1, 2017, 00:00

  • Budget Impact of A New, First-In-Class Triple Fixed Dose Combination Therapy For COPD Patients

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece

    Oct 1, 2017, 00:00

  • Case-Control Study on Risk Factors for Cancer from the Epidemiological Survey Carried Out on Beneficiaries of a Private Health Care Plan in Brazil- 10 Years of Follow-Up

    Oct 1, 2017, 00:00

  • Applying The Institute For Clinical And Economic Review’s (ICER) Methodology To Canada- An Improved Way To Take Into Consideration Drug Affordability Challenges?

    Oct 1, 2017, 00:00

  • Bibliometric Analysis of the Worldwide Research Productivity on Oral Health Related Quality of Life (Ohrql)

    Oct 1, 2017, 00:00

  • The First EQ-5D-5L Value Set In Central And Eastern Europe

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Tocilizumab, Infliximab and Etanercept Drugs for The Treatment of Rheumatoid Arthritis in Ecuador

    Oct 1, 2017, 00:00

  • Correlation of Minimal Clinically Important Differences Between Patient Reported Outcome Measures Related To Spinal Surgery

    Oct 1, 2017, 00:00

  • Hypertension Medication Access and Self-Management Among the Elderly by Education- Insights from the 2013 USA Medicare Current Beneficiary’s Survey

    Oct 1, 2017, 00:00

  • Healthcare Costs Of Patients With Acute And Chronic Graft-Versus-Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation In Belgium- A Retrospective Data Collection And Analysis

    Oct 1, 2017, 00:00

  • Percepción De La Competencia En El Mercado De Medicamentos Esenciales Y Huérfanos En Panamá

    Oct 1, 2017, 00:00

  • Analyzing Ovarian Cancer Recurrence After Tumor Resection in Other Sites Through The Brazilian Public Healthcare Claim Databases (DATASUS)

    Oct 1, 2017, 00:00

  • Evaluation Of New Biologic Starts And Switching Among Real-World Rheumatoid Arthritis Patients In The United States

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Alemtuzumab In The Treatment of Relapsing Forms of Multiple Sclerosis In The United States and Societal Spillover Effects

    Oct 1, 2017, 00:00

  • Integrated 2 Screw Cepahlo-Medulary Device Reduces Device Related Post-Operative Complications and Pain After Intertrochanteric Fractures, Evidence From a Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Quantifying Standard Of Care (SOC) Hospital-Related Resource Utilisation For Metastatic Uveal Melanoma (MUM) Patients In Nhs England (NHSE) Using The Hospital Episodes Statistics (HES) Dataset

    Oct 1, 2017, 00:00

  • Model Types Submitted To Ni What Is Considered Appropriate By Evidence Review Groups?

    Oct 1, 2017, 00:00

  • Health Care Resource Use (HCRU) Due To Bleeding Related Episodes (BRE) In Patients With Immune Thrombocytopenic Purpura (ITP) Receiving Eltrombopag (EPAG), Romiplostim (ROMI), Or Rituximab (RITUX)- Real World Evidence (RWE) From 27 US Insti ...

    Oct 1, 2017, 00:00

  • Optimal Usage of Sacubitril/Valsartan For Heart Failure Treatment In Canada Potentially Reduces Mortality, Hospitalizations And Early Discharge Re-Admissions

    Oct 1, 2017, 00:00

  • Economic Burden of Chronic Respiratory Diseases In Austria

    Oct 1, 2017, 00:00

  • Inclusion Of Safety/ADR-Related Outcomes In Economic Evaluations For Seasonal Influenza Vaccines- A Review Of Available Studies

    Oct 1, 2017, 00:00

  • Idiopathic Pulmonary Fibrosis- A Cost Of Illness Analysis In Greece

    Oct 1, 2017, 00:00

  • Influence Of Disease Familiarity On Implied Time Preferences For Seizure Frequency Reduction

    Oct 1, 2017, 00:00

  • Network Meta-Analysis of Treatments For Unresectable Hepatocellular Carcinoma

    Oct 1, 2017, 00:00

  • Predicting The Future Costs of Cancer Based on Register Data and Innovation Trends

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Daratumumab in Heavily Pre-Treated Multiple Myeloma Patients for The Italian Healthcare System

    Oct 1, 2017, 00:00

  • Evaluación Económica De Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir En El Tratamiento De La Infección Crónica Por Hepatitis C En Uruguay

    Oct 1, 2017, 00:00

  • Method Of Extrapolation- Estimation Of The Impact Of The Proportional Hazard Assumption On The Efficacy Estimation

    Oct 1, 2017, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Ankylosing Spondylitis at 52 Weeks from the Irish Payer Perspective

    Oct 1, 2017, 00:00

  • Cost Analysis of Pre-Dialysis- A Model in the Brazilian context

    Oct 1, 2017, 00:00

  • Assessing The Disease Course And Treatment of Psoriatic Arthritis (PSA) In Canada

    Oct 1, 2017, 00:00

  • Patient Characteristics and Disease Burden of Psoriasis In Mexico- A Real-World Physician and Patient Survey

    Oct 1, 2017, 00:00

  • Persistence, Compliance And Bisphosphonate Switching In Patients With Multiple Myeloma (MM) In Germany

    Oct 1, 2017, 00:00

  • Quality of Life in Patients with Kidney Transplantation in Czech Republic

    Oct 1, 2017, 00:00

  • Measuring The Intensity Of Care Coordination For Blood Cancer Patients In France

    Oct 1, 2017, 00:00

  • Financial Impact of Introducing Sc Trastuzumab (HERCEPTIN) Versus Currently Used IV Trastuzumab (HERCEPTIN) on The Budgets of Different Hospitals Across Kingdom of Saudi Arabia (KSA)

    Oct 1, 2017, 00:00

  • The Cost Of Dialectic Behaviour Therapy (DBT) For People Diagnosed With Borderline Personality Disorder (BPD)- A Review of The Literature

    Oct 1, 2017, 00:00

  • An Exploration of the Methodology of Published Systematic Literature Reviews on “Burden of Disease”

    Oct 1, 2017, 00:00

  • Evaluating The Annual Cost Per Response Rate of Pirfenidone And Nintedanib For The Treatment of Patients With Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • Exploratory Analysis Of The Reasons For Creating Worldwide Translations Of Patient Reported Outcome Instruments

    Oct 1, 2017, 00:00

  • Estimación De Costos De Los Servicios De Hemodiálisis Crónica Y Hemodiafiltración EN Argentina

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Ivabradine In The Treatment Of Chronic Heart Failure From The Mexican Perspective

    Oct 1, 2017, 00:00

  • Treatment with Biological Agents Among Patients with Ankylosing Spondylitis in Germany- A Claims Data Analysis

    Oct 1, 2017, 00:00

  • 2017 Update of Recent Trends in Multiple Sclerosis-Related Health Technology Assessment Decisions- An Assessment of Five Countries

    Oct 1, 2017, 00:00

  • Calculating The Return On Investment For Ifn-Free DAAS- The Case Of Greece

    Oct 1, 2017, 00:00

  • Rate of Hospitalization Due To Adverse Event and Length of Stay for Atezolizumab in Second and Third Line Metastatic Non-Small Lung Cancer (NSCLC) Using Phase 3 Oak Study

    Oct 1, 2017, 00:00

  • Wound Management In Diabetic Foot Ulcer (DFU) - Incremental Cost-Analysis Of Treating Diabetic Neuropathic Foot Lesions With Adjunct Hemoglobin Contact Spray In Germany

    Oct 1, 2017, 00:00

  • Estimation Of The Health-Related Quality Of Life Benefits Of Treatment For Spinal Muscular Atropy (SMA)

    Oct 1, 2017, 00:00

  • Network Meta-Analysis In The Evaluation of Vaccines

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Deep-Vein Thrombosis In Europe – Healthcare Resource Utilization And Productivity Loss

    Oct 1, 2017, 00:00

  • Testing The Beacon Tool With Health Economists And Clinicians – Is There Consistency In Its Application?

    Oct 1, 2017, 00:00

  • Can The Barthel IndeX (BI) Be Reliably Used Within Economic Evaluation? An Examination Of The Complementarity Of The BI And The Euroqol 5 Dimensions 3 Level (EQ-5D-3L)

    Oct 1, 2017, 00:00

  • Impact of Comprehensive Genomic Profiling of Patients With First Line Non-Small Cell Lung Cancer In The UK

    Oct 1, 2017, 00:00

  • Update on Impact of The Additional Benefit Extent of Orphan Drugs on Price Negotiations In The German Outpatient Sector

    Oct 1, 2017, 00:00

  • How Does The Scottish Medicines Consortium Assess The Value Of Orphan And Ultra-Orphan Drugs?

    Oct 1, 2017, 00:00

  • “It’s All Relative” – Exploring The Challenges During Cultural Adaptation Of Family Names In PRO (Patient Reported Outcomes) Questionnaires

    Oct 1, 2017, 00:00

  • Trends In Oncology Appraisal Decisions- A Comparison Between The National Institute For Health And Care Excellence (NICE) And The Scottish Medicines Consortium (SMC)

    Oct 1, 2017, 00:00

  • How Beneficial Is Individual Patient Data In A Mixed Treatment Comparison?

    Oct 1, 2017, 00:00

  • Prevalence And Treatment Cost of Non-Communicable Diseases Related To Smoking In Indonesia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of PET/CT In Pre-Operative Staging Of Pancreatic Cancer- An Economic Evaluation Of The PET-PANC Cohort Study

    Oct 1, 2017, 00:00

  • One-Center Analysis of Cost Associated With Acromegaly Management In Poland

    Oct 1, 2017, 00:00

  • The Economic Evaluation Of Continuous Ambulatory Peritoneal Dialysis (CAPD) and Hemodialysis In Indonesia

    Oct 1, 2017, 00:00

  • Assessing the Burden of Disease in Peripheral and Axial Spondyloarthritis in Mexico and Brazil

    Oct 1, 2017, 00:00

  • Economic Analysis Of The Lutonix® 035 Drug Coated Balloon Pta Catheter For The Treatment Of Vascular Access Stenosis In Patients With Arteriovenous Fistulas

    Oct 1, 2017, 00:00

  • The Burden of Urothelial Carcinoma for the Brazilian Public Health System- A National Retrospective Analysis From 2013 TO 2016

    Oct 1, 2017, 00:00

  • Resultados Econômicos Da Gestão Clínica De Antimicrobianos Realizados Por Uma Operadora De Plano De Saúde Em Fortaleza-Brasil

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis Comparing the Originator Recombinant Human Alfa to their Biosimilars Follitropin Alfa for the Treatment of Infertility

    Oct 1, 2017, 00:00

  • Costos De La Hipoglucemia En Colombia

    Oct 1, 2017, 00:00

  • Incidence and Costs of Hypoglycemia In Diabetes Patients Initiated On Basal Insulin- A Population-Based Study

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A 0.2 Μg/Day Fluocinolone Acetonide (FAC) Implant In The Treatment Chronic Diabetic Macular Oedema (DMO) In The UK

    Oct 1, 2017, 00:00

  • Dry-Weight Assessment Among Hemodialysis Patients Using Body Composition Monitor

    Oct 1, 2017, 00:00

  • An Economic Evaluation of A Psychoeducational Suicide Intervention Programme

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Lidocaine Medicated Patch Compared with Pregabalin and Gabapentin for the Treatment of Postherpetic Neuralgia an Diabetic Polyneuropathy in Colombia

    Oct 1, 2017, 00:00

  • Treatment Strategies and Outcomes In Patients Treated For Relapsed Refractory Multiple Myeloma Over 3 Years- Premiere Study

    Oct 1, 2017, 00:00

  • A Systematic Review On Lifestyle Change Interventions Performed By Health Care Professionals Targeting Blood Pressure In Hypertensive Patients

    Oct 1, 2017, 00:00

  • High-Cost Oncology Drugs in Brazil and Mexico- Access Differences Between the Public and Private Settings

    Oct 1, 2017, 00:00

  • Qualitative Exploration of the Real-World Experiences of Men Receiving or Refusing Chemotherapy (Docetaxel) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (MHSPC)

    Oct 1, 2017, 00:00

  • How Ireland's Colorectal Screening Programme Could Save More Lives, Save Money and Stay Within Existing Colonoscopy Capacity Limits- Evidence from the Miscan Microsimulation Model

    Oct 1, 2017, 00:00

  • Costs of Illness Progression for Different Multiple Sclerosis Phenotypes- A Population-Based Study in Sweden

    Oct 1, 2017, 00:00

  • Evaluation of The "Sophia Asthme" Support Programme for Asthmatic Adult Patients

    Oct 1, 2017, 00:00

  • Concept of Pharmaceutical Care In The Brazilian Legislation

    Oct 1, 2017, 00:00

  • Well Thought Through But Badly Carried Out- An Evaluation Of The Reporting Quality Of Statutory Health Insurance Claims Data Analyses To Quantify The Target Population In Early Benefit Assessment In Germany

    Oct 1, 2017, 00:00

  • Patient Burden of Rheumatoid Arthritis- Results of a Global Systematic Literature Review on Disability, Work Disruption, and Functional Capability in the Real World

    Oct 1, 2017, 00:00

  • Resource Use and Associated Costs of Managing Docetaxel-Related Neutropenic Sepsis in Patients with Advanced Non-Small Cell Lung Cancer in The UK Nhs- Reveal-Ns

    Oct 1, 2017, 00:00

  • Burden Of Endometriosis And Related Symptoms In A Nationwide Health Plan With 2 Million Members

    Oct 1, 2017, 00:00

  • Compliance And Treatment Satisfaction With Biological Treatments For Systemic Juvenile Idiopathic Arthritis (SJIA)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Empagliflozin (Jardiance®) In The Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) In Turkey Based Empa-Reg Outcome Data

    Oct 1, 2017, 00:00

  • Comparison of Icd-9 to Icd-10 Crosswalks Derived By Physician and Clinical Coder Vs. Automated Methods

    Oct 1, 2017, 00:00

  • Cost –Effectiveness of Obinutuzumab As Frontline Treatment For Unfit Patients With Chronic Lymphocytic Leukemia In Republic of Macedonia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Additional Vaccination of Boys Against HPV In Germany

    Oct 1, 2017, 00:00

  • Cost Efficiency Analysis of A New Arrhythmia Detection Algorithm In A Miniaturized Insertable Cardiac Monitor

    Oct 1, 2017, 00:00

  • Quimioterápicos Orais No Tratamento De Segunda Linha Do Carcinoma De Células Renais- Comparação De Custos E Perfil De Reações Adversas

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Moderate-to-Severe Plaque Psoriasis Patients in Brazil

    Oct 1, 2017, 00:00

  • A Survey On The Society's Awareness Level On Aids In Turkey

    Oct 1, 2017, 00:00

  • How Can Middle-Income Countries Get A Valid Estimate Of Cost-Effectiveness Of A Drug More Efficiently And Effectively?

    Oct 1, 2017, 00:00

  • Increased Prevalence of Diabetes In The Netherlands Is Only Partly Explained By Changes In Age And Sex Over Time

    Oct 1, 2017, 00:00

  • Understanding Health Technology Assessment Outcomes For Products With Conditional Market Authorisation In Fran Initial Evaluation VS. Re-Assessment

    Oct 1, 2017, 00:00

  • Impact of Global Budget on Personal Medical Expense for Inpatient with Respiratory Disease- An Interrupted Time Series Analysis

    Oct 1, 2017, 00:00

  • Shouldn’t Nice Cost-Effectiveness Thresholds Be Changing With The Times?

    Oct 1, 2017, 00:00

  • How to Maintain Pharmaceutical Access in Crisis- The Iran FDA Experience

    Oct 1, 2017, 00:00

  • Comparative Study Of Healthcare Resource Utilization (HRU) Outcomes Between Chronic Lymphocytic Leukemia (CLL) Patients Treated With Ibrutinib Versus Non-Ibrutinib Treated Patients

    Oct 1, 2017, 00:00

  • Understanding The Barriers To Vaccine Access And Uptake In EU5- Rotavirus Vaccination Case Study

    Oct 1, 2017, 00:00

  • Economic Analysis of Hepato Cellular Carcinoma Treatment by Severity of Disease

    Oct 1, 2017, 00:00

  • Breast Cancer Diagnosis Process- An Integrative Evaluation of Five Components

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis Of Dalbavancin Use In Acute Bacterial Skin And Soft Tissue Infections

    Oct 1, 2017, 00:00

  • Population Health Status Based On The EQ-5D-3L-Y Among Adolescents In Sweden - Results By Sex, Age And Socio-Economic Status

    Oct 1, 2017, 00:00

  • Budget Impact of Alteplase In Treatment of Acute Ischemic Stroke In Turkey

    Oct 1, 2017, 00:00

  • Sun Protection Knowledge And Behaviour Among University Students In Hungary

    Oct 1, 2017, 00:00

  • Secukinumab Vs. Adalimumab for Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis at 52 Weeks from an Argentinian Perspective

    Oct 1, 2017, 00:00

  • Cost Drivers of Lung Cancer Care- Results From A Retrospective Chart Review of Pretreated Advanced Nsclc Patients in Europe

    Oct 1, 2017, 00:00

  • Assessment of Public Opinion Regarding The Ethics of Nice CDF, HST, and End-of-Life Criteria for Drug Reimbursement

    Oct 1, 2017, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78 (current)
  • 79
  • 80
  • »